(Q36220940)

12 August 2017

Adult Onset Still's Disease and Autoinflammation (English)

1 reference

12 August 2017

1 reference

5

Bruno Fautrel

1 reference

12 August 2017

Petros Efthimiou

1

1 reference

12 August 2017

L Nandini Moorthy

series ordinal

2

1 reference

12 August 2017

Clio P Mavragani

series ordinal

3

1 reference

12 August 2017

Dimitris Skokos

series ordinal

4

1 reference

12 August 2017

29 August 2012

1 reference

International Journal of Inflammation

12 August 2017

1 reference

12 August 2017

2012

1 reference

12 August 2017

964751

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

IL-18 Serum Level in Adult Onset Still's Disease: A Marker of Disease Activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Ferritin in adult-onset still's disease: just a useful innocent bystander?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Systemic arthritis in children: a review of clinical presentation and treatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Efficacy of abatacept in a refractory case of adult-onset Still's disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Pathogenesis and management of adult-onset Still's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Diffuse alveolar hemorrhage

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Longterm outcome of TNF blockade in adult-onset Still's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Serum cytokine profiles in patients with adult onset Still's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Etanercept in the treatment of adult patients with Still's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Thrombotic thrombocytopenic purpura in adult Still's disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Still's disease in the adult

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Preliminary criteria for classification of adult Still's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Refractory adult-onset still disease successfully treated with abatacept

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Th17 response and inflammatory autoimmune diseases

29 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F964751

Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F964751

Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437651

Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan

22 September 2018

1 reference

12 December 2020

Fulminant hepatic failure in adult onset Still's disease

1 reference

12 December 2020

A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years

1 reference

12 December 2020

Proposal for a new set of classification criteria for adult-onset still disease

1 reference

12 December 2020

Interleukin 6: a possible marker of disease activity in adult onset Still's disease

1 reference

12 December 2020

Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade

1 reference

12 December 2020

Adult-onset Still's disease

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/964751

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22988543

1 reference